ILS Pharmaceutical Division increases storage stability

Published: 17-Aug-2010
Manufacturing Regulatory

New walk-in cabinet brings combined capacity to more than 40,000 litres


As part of its continued investment and expansion plans in the Pharmaceutical Division, ILS has welcomed the arrival of its brand new walk-in 25ºC / 60%RH, ICH storage stability cabinet. The company can now offer more than double the capacity of its most popular storage condition.

The completion of the installation and commissioning means an increase in capacity of ILS’s walk-in chambers by greater than 30%. The company’s suite of walk-in Stability Chambers now totals four with a combined capacity in excess of 40,000 litres.

This is complemented by a range of stand-alone storage cabinets that can be set at client specific requirements. Clients can feel assured in the knowledge that their samples are in chambers that have 24 hour monitoring, 365 days of the year.

Contact any member of the Business Development team on +44 1332 793 000 for further information on this exciting new increase in our capabilities.

  • Companies:
  • ILS International Laboratory Services
See more

You may also like

Regulatory

Pharmaceutical heavy metals detection now requires high technology equipment

Read more
A proposed change in the USP test for heavy metals will involve a considerable investment in equipment, training and technology for many organisations

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the vaccine candidate drug substance commencing late in the third quarter of 2020
  2. Isospec Analytics launches biomolecular analysis technology to identify unknown molecules The novel technology optimises the identification process of unknown molecules compared to mass analysis
  3. ten23 health and Ypsomed collaborate to commercialise the YpsoDose patch injector The partnership will bring the drug delivery device to the pharmaceutical market quicker, whilst reducing development risks
  4. Naobios and Sumagen sign exclusive partnership to develop HIV vaccine Naobios will manage process development and initiate launch of cGMP manufacturing for phase II clinical trials
  5. 4SC AG receives Paediatric Investigation Plan waiver for resminostat from the UK MHRA The waiver allows the company to avoid investigating the CTCL drug in a paediatric population, as it's considered unnecessary or inappropriate for use by this patient group

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

You may also like

Regulatory

Pharmaceutical heavy metals detection now requires high technology equipment

A proposed change in the USP test for heavy metals <231> will involve a considerable investment in equipment, training and technology for many organisations
Regulatory

ILS makes further progress with new facility

All media will now be produced in house, giving greater flexibility to meet the changing requirements of customers
Regulatory

ILS wins award for Outstanding Achievement

At the Medilink East Midlands Business Awards
Manufacturing

Pharmaceutical heavy metals detection now requires high tech equipment

Proposed changes to testing for heavy metals in the USP and Ph Eur will have an impact on the testing and development of drugs and dietary supplements for consumption in the US and European marketplace
Regulatory

ILS’ plans to return to full operations after recent fire progress to schedule

Sets up temporary lab space for pharma and food microbiology services destroyed in blaze
Regulatory

Fire damages microbiology department at ILS

Derbyshire Fire & Rescue Service to carry out an investigation to establish the cause
Regulatory

International Laboratory Services passes audit

Shardlow site undergoes another successful US FDA audit
Subscribe now